Emma M. Quinn

12.9k total citations · 2 hit papers
18 papers, 1.8k citations indexed

About

Emma M. Quinn is a scholar working on Genetics, Oncology and Cancer Research. According to data from OpenAlex, Emma M. Quinn has authored 18 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 6 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Emma M. Quinn's work include HER2/EGFR in Cancer Research (6 papers), Estrogen and related hormone effects (4 papers) and Breast Cancer Treatment Studies (4 papers). Emma M. Quinn is often cited by papers focused on HER2/EGFR in Cancer Research (6 papers), Estrogen and related hormone effects (4 papers) and Breast Cancer Treatment Studies (4 papers). Emma M. Quinn collaborates with scholars based in Ireland, United Kingdom and United States. Emma M. Quinn's co-authors include Janine Salter, Mitch Dowsett, Aman U. Buzdar, John Forbes, Jack Cuzick, Christopher Wale, Anthony Howell, Ian O. Ellis, Lila Zabaglo and Sílvia Pineda and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Emma M. Quinn

16 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study

2010 546 citations Mitch Dowsett, Jack Cuzick et al. Journal of Clinical Oncology profile →
Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer

2011 540 citations Jack Cuzick, Mitch Dowsett et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Emma M. Quinn

Since Specialization

Citations

This map shows the geographic impact of Emma M. Quinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma M. Quinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma M. Quinn more than expected).

Fields of papers citing papers by Emma M. Quinn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma M. Quinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma M. Quinn. The network helps show where Emma M. Quinn may publish in the future.

Co-authorship network of co-authors of Emma M. Quinn

This figure shows the co-authorship network connecting the top 25 collaborators of Emma M. Quinn. A scholar is included among the top collaborators of Emma M. Quinn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma M. Quinn. Emma M. Quinn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	P1300 HLA-C06 Genotype and Ustekinumab Therapy Persistence in Inflammatory Bowel Disease 2025 ·Journal of Crohn s and Colitis* ·(unknown), Anthony W. Ryan, (unknown), Emma M. Quinn, Ronán Conroy, (unknown), G Cullen, Juliette Sheridan, Yvonne Bailey, Cara Dunne, (unknown), Deirdre McNamara, Glen Doherty, David Kevans	0
2	HLA-DQA105* Allele Carriage and Anti-TNF Therapy Persistence in Inflammatory Bowel Disease 2024 ·Inflammatory Bowel Diseases ·(unknown), Anthony W. Ryan, Emma M. Quinn, Judith Conroy, (unknown), (unknown), (unknown), Garret Cullen, Juliette Sheridan, Yvonne Bailey, Cara Dunne, (unknown), Deirdre McNamara, Glen Doherty, David Kevans	3
3	Sa1796 HLA-DQA105 ALLELE CARRAIGE AND ANTI-TNF THERAPY PERSISTENCE IN INFLAMMATORY BOWEL DISEASE 2023 ·Gastroenterology* ·(unknown), Anthony W. Ryan, Emma M. Quinn, (unknown), (unknown), (unknown), Yvonne Bailey, Deirdre McNamara, Glen Doherty, David Kevans	1
4	Quality Control and Analysis of NGS RNA Sequencing Data 2015 ·Methods in molecular biology ·Emma M. Quinn, Ross McManus	0
5	Quality Control Procedures for High-Throughput Genetic Association Studies 2015 ·Methods in molecular biology ·(unknown), Emma M. Quinn, Ross McManus	2
6	Spontaneous atopic dermatitis is mediated by innate immunity, with the secondary lung inflammation of the atopic march requiring adaptive immunity 2015 ·Journal of Allergy and Clinical Immunology ·Sean P. Saunders, Tara Moran, Achilleas Floudas, (unknown), (unknown), Maryam Salimi, Emma M. Quinn, (unknown), Gabriel Núñez, Ross McManus, Emily Hams, Alan D. Irvine, Andrew N. J. McKenzie, Graham S. Ogg, Padraic G. Fallon	121
7	Common polygenic variation in coeliac disease and confirmation of ZNF335 and NIFA as disease susceptibility loci 2015 ·European Journal of Human Genetics ·(unknown), Emma M. Quinn, Anthony W. Ryan, Judith Conroy, Valerie Trimble, Nasir Mahmud, Nicholas A. Kennedy, Aiden Corvin, Derek W. Morris, Gary Donohoe, Colm O’Morain, Padraic MacMathúna, Valerie Byrnes, (unknown), Gosia Trynka, Cisca Wijmenga, Dermot Kelleher, Sean Ennis, Richard Anney, Ross McManus	27
8	Transcriptome Analysis of CD4+ T Cells in Coeliac Disease Reveals Imprint of BACH2 and IFNγ Regulation 2015 ·PLoS ONE ·Emma M. Quinn, (unknown), (unknown), Patricia Domínguez Castro, Paul Cormican, Valerie Trimble, Nasir Mahmud, Ross McManus	29
9	Development of Strategies for SNP Detection in RNA-Seq Data: Application to Lymphoblastoid Cell Lines and Evaluation Using 1000 Genomes Data 2013 ·PLoS ONE ·Emma M. Quinn, Paul Cormican, Elaine Kenny, Matthew Hill, Richard Anney, Michael Gill, Aiden Corvin, Derek W. Morris	91
10	Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer breakdown → 2011 ·Journal of Clinical Oncology ·Jack Cuzick, Mitch Dowsett, Sílvia Pineda, Christopher Wale, Janine Salter, Emma M. Quinn, Lila Zabaglo, Elizabeth Mallon, Andrew R. Green, Ian O. Ellis, Anthony Howell, Aman U. Buzdar, John Forbes	540
11	P2-12-09: Prediction of Residual Risk of Recurrence after 5 Years of Follow-Up by Clinicopathologic Variables and 4 IHC Markers: A TransATAC Study. 2011 ·Cancer Research ·Ivana Šestak, J. Cuzick, Mitch Dowsett, Janine Salter, Emma M. Quinn, Lila Zabaglo, (unknown), A. U. Buzdar, JF Forbes	1
12	Evidence for cis‐acting regulation of ANK3 and CACNA1C gene expression 2010 ·Bipolar Disorders ·Emma M. Quinn, Matthew Hill, Richard Anney, Michael Gill, Aiden Corvin, Derek W. Morris	25
13	Comparative validation of the SP6 antibody to Ki67 in breast cancer 2010 ·Journal of Clinical Pathology ·Lila Zabaglo, Janine Salter, H Anderson, Emma M. Quinn, Margaret Hills, Simone Detre, Roger A’Hern, Mitch Dowsett	49
14	Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study breakdown → 2010 ·Journal of Clinical Oncology ·Mitch Dowsett, Jack Cuzick, Christopher Wale, John Forbes, Elizabeth A. Mallon, Janine Salter, Emma M. Quinn, Anita K. Dunbier, Michael Baum, Aman U. Buzdar, Anthony Howell, Roberto Bugarini, Frederick L. Baehner, Steven Shak	546
15	Influence of NOS1 on Verbal Intelligence and Working Memory in Both Patients With Schizophrenia and Healthy Control Subjects 2009 ·Archives of General Psychiatry ·Gary Donohoe, James Walters, Derek W. Morris, Emma M. Quinn, (unknown), Nadine Norton, Ina Giegling, Annette M. Hartmann, (unknown), Pierandrea Muglia, Hywel Williams, Valentina Moskvina, (unknown), (unknown), Michael J. Owen, Michael O’Donovan, Michael Gill, Dan Rujescu, Aiden Corvin	36
16	Relationship Between Quantitative Estrogen and Progesterone Receptor Expression and Human Epidermal Growth Factor Receptor 2 (HER-2) Status With Recurrence in the Arimidex, Tamoxifen, Alone or in Combination Trial 2008 ·Journal of Clinical Oncology ·Mitch Dowsett, Craig Allred, Jill Knox, Emma M. Quinn, Janine Salter, (unknown), Jack Cuzick, Joan Houghton, Norman Williams, Elizabeth Mallon, Hugh Bishop, Ian O. Ellis, Denis Larsimont, Hironobu Sasano, P J Carder, Antonio Llombart‐Cussac, Fiona Knox, Valerie Speirs, John Forbes, Aman U. Buzdar	335
17	Concordance between tissue microarray and whole tissue sections for ER expression and PgR and HER-2 status: a pilot study for the Trans-ATAC trial 2008 ·European Journal of Cancer Supplements ·Emma M. Quinn, Janine Salter, Margaret Hills, Mitch Dowsett	3
18	The farnesyltransferase inhibitor R115777 (tipifarnib) in combination with tamoxifen acts synergistically to inhibit MCF-7 breast cancer cell proliferation and cell cycle progression in vitro and in vivo 2007 ·Molecular Cancer Therapeutics ·Lesley‐Ann Martin, Julia E. Head, Sunil Pancholi, Janine Salter, Emma M. Quinn, Simone Detre, Stan B. Kaye, Angela Howes, Mitch Dowsett, Stephen Johnston	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact